指南与共识腹部技术与安全US

胃肠病学中超声内镜引导下取样的适应证、结果与临床影响:欧洲胃肠道内镜学会(ESGE)临床指南——2017年1月更新

Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated January 2017.
指南 / 共识 · Endoscopy · 2017-05-16

该ESGE指南针对胰腺实性及囊性病变、食管癌、不明原因淋巴结肿大及可疑肝转移瘤等情形,给出了超声内镜引导下取样的推荐意见及证据等级,涵盖一线取样、阴性结果处理、囊液分析及淋巴结评估等临床决策要点。

要点

  • 胰腺实性病变需病理诊断时,推荐EUS引导下取样作为一线操作(强推荐,中等质量证据)。
  • 胰腺囊性病变若精确诊断可能改变处理且直径>10 mm或有高危标志,推荐EUS取样行生化及细胞学检查(强推荐,低质量证据)。
  • 不明原因淋巴结肿大且病理结果可能影响处理时,推荐EUS或EBUS引导下取样(强推荐,中等质量证据)。

核心结论

  • ESGE针对胰腺实性病变、胰腺囊性病变、食管癌分期、不明原因淋巴结肿大及可疑肝转移瘤的EUS引导下取样给出了分级推荐。
  • 胰腺实性病变需病理诊断时推荐EUS取样为一线;阴性或不确定且高度怀疑恶性时可复核病理、重复EUS取样或手术(弱推荐,低质量证据)。
  • 慢性胰腺炎伴胰腺肿块时,EUS取样未证实癌的结果应谨慎解读(强推荐,低质量证据)。
  • 胰腺囊性病变若精确诊断可能改变处理,推荐EUS取样行生化分析加细胞病理检查,但直径≤10 mm且无高危标志的病变除外;囊液量少时首选癌胚抗原(CEA)测定(强推荐,低质量证据)。

研究设计与样本

  • 欧洲胃肠道内镜学会(ESGE)临床指南,2017年1月更新,采用推荐强度与证据质量分级表述。

诊断标准与关键数值

  • 胰腺实性病变:需病理诊断时EUS取样为一线(强推荐,中等质量证据);转移性疾病可考虑经皮取样。
  • 胰腺实性病变阴性/不确定且高度怀疑恶性:建议复核病理切片、重复EUS取样或手术(弱推荐,低质量证据)。
  • 慢性胰腺炎伴肿块:EUS取样未证实癌应谨慎解读(强推荐,低质量证据)。
  • 胰腺囊性病变:精确诊断可能改变处理时推荐EUS取样行生化加细胞病理,但直径≤10 mm且无高危标志者除外;囊液量少时首选CEA测定(强推荐,低质量证据)。
  • 食管癌:T1(及视局部治疗政策T2)腺癌评估区域淋巴结、可疑远处转移(远处淋巴结、左肝叶病变、可疑腹膜癌病)时建议EUS取样(弱推荐,低质量证据)。

临床应用与阅片要点

  • 胰腺实性病变需病理确诊时,EUS引导下取样作为一线操作(强推荐,中等质量证据);转移性疾病可考虑经皮取样。
  • 胰腺实性病变EUS取样阴性或不确定而恶性怀疑度高时,建议复核病理切片、重复EUS取样或手术(弱推荐,低质量证据)。
  • 慢性胰腺炎伴胰腺肿块者,EUS取样未证实癌的结果应谨慎解读(强推荐,低质量证据)。
  • 胰腺囊性病变精确诊断可能改变处理时,推荐EUS取样行生化分析加细胞病理检查,但直径≤10 mm且无高危标志者除外;囊液量少时首选CEA测定(强推荐,低质量证据)。
  • 不明原因淋巴结肿大且病理结果可能影响处理、无浅表淋巴结易及时,推荐EUS(或EBUS)引导下取样(强推荐,中等质量证据)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

For pancreatic solid lesions, ESGE recommends performing endoscopic ultrasound (EUS)-guided sampling as first-line procedure when a pathological diagnosis is required. Alternatively, percutaneous sampling may be considered in metastatic disease.Strong recommendation, moderate quality evidence.In the case of negative or inconclusive results and a high degree of suspicion of malignant disease, ESGE suggests re-evaluating the pathology slides, repeating EUS-guided sampling, or surgery.Weak recommendation, low quality evidence.In patients with chronic pancreatitis associated with a pancreatic mass, EUS-guided sampling results that do not confirm cancer should be interpreted with caution.Strong recommendation, low quality evidence.For pancreatic cystic lesions (PCLs), ESGE recommends EUS-guided sampling for biochemical analyses plus cytopathological examination if a precise diagnosis may change patient management, except for lesions ≤ 10 mm in diameter with no high risk stigmata. If the volume of PCL aspirate is small, it is recommended that carcinoembryonic antigen (CEA) level determination be done as the first analysis.Strong recommendation, low quality evidence.For esophageal cancer, ESGE suggests performing EUS-guided sampling for the assessment of regional lymph nodes (LNs) in T1 (and, depending on local treatment policy, T2) adenocarcinoma and of lesions suspicious for metastasis such as distant LNs, left liver lobe lesions, and suspected peritoneal carcinomatosis.Weak recommendation, low quality evidence.For lymphadenopathy of unknown origin, ESGE recommends performing EUS-guided (or alternatively endobronchial ultrasound [EBUS]-guided) sampling if the pathological result is likely to affect patient management and no superficial lymphadenopathy is easily accessible.Strong recommendation, moderate quality evidence.In the case of solid liver masses suspicious for metastasis, ESGE suggests performing EUS-guided sampling if the pathological result is likely to affect patient management, and (i) the lesion is poorly accessible/not detected at percutaneous imaging, or (ii) a sample obtained via the percutaneous route repeatedly yielded an inconclusive result.Weak recommendation, low quality evidence.

来源:Endoscopy,查看原文。版权归原作者所有。

引用

  1. Dumonceau JM, Deprez PH, Jenssen C, et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated January 2017. Endoscopy. 2017. PMID: 28511234. doi:10.1055/s-0043-109021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。